Scientific Advisory Board
Len Post has over thirty years experience in R&D at pharmaceutical and biotech companies. He is currently Chief Scientific Officer at Vivace Therapeutics. His previous position was Chief Scientific Officer of BioMarin Pharmaceutical, a company focused on rare genetic disease, where he was responsible for programs that included small molecules, proteins, and gene therapy. Prior positions were Chief Scientific Officer of LEAD Therapeutics, Senior Vice President of R&D at Onyx Pharmaceuticals, and positions at Parke-Davis and Upjohn. He is currently a member of the boards of directors of Vivace, Oxyrane, Orphagen, and Fedora Pharmaceuticals.